Skip to Content

APO MYC500 (Mycophenolate mofetil 500 mg)

Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate mofetil 500 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; bullous pemphigoid; organ transplant, rejection prophylaxis; cogan's syndrome; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for APO MYC500

Mycophenolate mofetil

500 mg
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
ferric oxide red
titanium dioxide
ferrosoferric oxide
microcrystalline cellulose
silicon dioxide
hydroxypropyl cellulose
propylene glycol
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0588 Amerisource Health Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.